These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 24754845)

  • 1. Patient selection for whole brain radiotherapy (WBRT) in a large lung cancer cohort: Impact of a new Dutch guideline on brain metastases.
    Hendriks LE; Troost EG; Steward A; Bootsma GP; De Jaeger K; van den Borne BE; Dingemans AM
    Acta Oncol; 2014 Jul; 53(7):945-51. PubMed ID: 24754845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
    Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
    J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC).
    Bohlen G; Meyners T; Kieckebusch S; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Rades D
    Clin Neurol Neurosurg; 2010 Apr; 112(3):183-7. PubMed ID: 19962229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients.
    Rades D; Schild SE; Lohynska R; Veninga T; Stalpers LJ; Dunst J
    Cancer; 2007 Sep; 110(5):1077-82. PubMed ID: 17614294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.
    Viani GA; Castilho MS; Salvajoli JV; Pellizzon AC; Novaes PE; Guimarães FS; Conte MA; Fogaroli RC
    BMC Cancer; 2007 Mar; 7():53. PubMed ID: 17386108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma knife radiosurgery for treatment of cerebral metastases from non-small-cell lung cancer.
    Motta M; del Vecchio A; Attuati L; Picozzi P; Perna L; Franzin A; Bolognesi A; Cozzarini C; Calandrino R; Mortini P; di Muzio N
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e463-8. PubMed ID: 21530098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
    Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastases.
    Videtic GM; Adelstein DJ; Mekhail TM; Rice TW; Stevens GH; Lee SY; Suh JH
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):240-3. PubMed ID: 17056192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
    Nieder C; Andratschke N; Grosu AL; Molls M
    Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
    Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
    Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases.
    Chidel MA; Suh JH; Reddy CA; Chao ST; Lundbeck MF; Barnett GH
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):993-9. PubMed ID: 10863070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linac radiosurgery versus whole brain radiotherapy for brain metastases. A survival comparison based on the RTOG recursive partitioning analysis.
    Kocher M; Maarouf M; Bendel M; Voges J; Müller RP; Sturm V
    Strahlenther Onkol; 2004 May; 180(5):263-7. PubMed ID: 15127155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
    Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.
    Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM
    J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Institutional, retrospective analysis of 777 patients with brain metastases: treatment outcomes and diagnosis-specific prognostic factors.
    Antoni D; Clavier JB; Pop M; Schumacher C; Lefebvre F; Noël G
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):630-7. PubMed ID: 23582409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a New Disease-specific Prognostic Score for Patients With Brain Metastases From Small-cell Lung Cancer Treated With Whole Brain Radiotherapy (BMS-Score) and Validation of Two Other Indices.
    Bernhardt D; König L; Aufderstrasse S; Krisam J; Hoerner-Rieber J; Adeberg S; Bozorgmehr F; El Shafie R; Lang K; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Marcrom S; Debus J; Steins M; Rieken S
    Clin Lung Cancer; 2018 Jul; 19(4):340-345. PubMed ID: 29373273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of brain metastases from non-small cell lung cancer.
    Baykara M; Kurt G; Buyukberber S; Demirci U; Ceviker N; Algin E; Coskun U; Aykol S; Emmez H; Ozet A; Benekli M
    J Cancer Res Ther; 2014; 10(4):915-21. PubMed ID: 25579528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
    Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
    Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors affecting survival after whole brain radiotherapy in patients with brain metastasized lung cancer.
    Tsakonas G; Hellman F; Gubanski M; Friesland S; Tendler S; Lewensohn R; Ekman S; de Petris L
    Acta Oncol; 2018 Feb; 57(2):231-238. PubMed ID: 28984492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.